Post on 22-Feb-2016
description
PA SPREADWebinar #2
Pre-Work Learning Objectives1.Understand the concept of empanelment and develop
a plan to organize patients into provider panels2.Develop an aim statement for what and how much
you want to improve over the next year.3.Understand the clinical guidelines and related
measures for diabetes.4.Collect baseline data on the number of diabetes
patients in your practice and the number of patients meeting evidence-based diabetes measures.
Three Baseline Assessments1. Practice Facilitator Pre-Work Visit Assessment2. PCMH Assessment (PCMH-A)3. Clinical Measures Baselines
“MEDICAL HOMENESS” BASELINEPCMH-Assessment (PCMH-A)
The PCMH-A• Self-assessment tool developed by Qualis and
the MacColl Institute for the Safety Net Medical Home Initiative.
• Assesses current level of “medical homeness.”• No right or wrong answers! Just assessment of
where you are in each area.• Should be completed at the practice level by the
team leader or provider champion in consultation with improvement team.
PCMH-A Assessment Areas1. Empanelment (discussed in Webinar #1)2. Continuous Relationships3. Patient-Centered Interactions4. Engaged Leadership5. Quality Improvement Strategy6. Enhanced Access7. Care Coordination8. Organized, Evidence-Based Care
Completing the PCMH-A• Emailed to key contacts from PA SPREAD and available
online at: http://www.safetynetmedicalhome.org/sites/default/files/PCMH-A.pdf.
• Answer questions in each assessment area.• Send us a copy of your completed PCMH-A by May 11
by email to paspread@hmc.psu.edu or fax it to 717-531-0182.
• We’ll score it for you and send it back to you for your files.
• It is typical to have low scores at this point!• Helpful to identify areas for improvement.
INITIAL CLINICAL FOCUSDiabetes
Why Start With Diabetes?• Prevalence: 9% in PA vs. 8.3% nationally.1
• Cost: $3.6 billion total hospital charges in PA from 2003-2007.1
• Clear, widely accepted evidence-based guidelines.• Requires “system of care” to provide:
• Clinical management of A1C, BP, LDL• Screenings for complications• Coordination with specialists• Patient self-management 1 T
he B
urde
n of
Dia
bete
s in
Penn
sylv
anai
, 201
0. P
A De
pt o
f Hea
lth:
http:
//w
ww
.por
tal.s
tate
.pa.
us/p
orta
l/ser
ver.p
t/co
mm
unity
/dia
bete
s/14
160/
diab
etes
_pub
licati
ons_
__do
cum
ents
/557
820.
Diagnosing Diabetes• HbA1C of 6.5% or higher• FBG of 126 or higher
Sou
rce:
Am
eric
an D
iabe
tes
Ass
ocia
tion.
D
iabe
tes
Car
e. J
anua
ry 2
012 35:S11-S63
. ht
tp://
care
.dia
bete
sjou
rnal
s.or
g/co
nten
t/35/
Sup
plem
ent_
1/S
64.fu
ll
Clinical Guidelines for Diabetes
• American Diabetes Association (ADA) guidelines in Diabetes Care January 2012 supplement:http://care.diabetesjournals.org/content/35/Supplement_1/S3.full• Evidence for the effectiveness of restructuring systems
of chronic care delivery under “Strategies for Improving Diabetes Care.”
Improving Diabetes Care• Focus of our collaborative work for the next year.• Together identify and implement strategies and
“best practices” to improve diabetes care.• Many ideas for you to test in your practice to see
if they work and how you might refine them.
CLINICAL QUALITY MEASURESUsing and Reporting
Importance of Clinical Measures• You can’t improve what you don’t measure.• Numerous national entities developing and endorsing
clinical measures.• National Committee on Quality Assurance (HEDIS and
PCMH 2011)• Centers for Medicare and Medicaid Services
(Meaningful Use)• National Quality Forum• American Medical Association
• Increasing public accountability demands— need a way to compare apples to apples.
The Math of Clinical Measures
Performance calculated with a fraction.
Numerator = # of Patients Meeting Specification
Denominator = # of Patients in Target Population
ExampleLet’s say you have 500 diabetes patients ages 18-75 in your practice. Of those, 250 have an A1C <8.0%. Your performance on this measure of good diabetes control would be 50%.
250 with A1C <8.0%500 patients in target population
= 50%
MEANINGFUL USE REQUIREMENTSClinical Quality Measures
THIS INITIATIVE WILL HELP YOU GET THERE!
Meaningful Use RequirementsTo attest for Meaningful Use, must:1. Meet 15 Core Objectives2. Meet 5 of 10 “Menu Set” Objectives3. Report on 3 Core Clinical Quality Measures
(or 3 alternate core) 4. Report on 3 More Clinical Quality Measures
15 Core Objectives (we’ll work on)
1. Computerized provider order entry.2. Drug-drug and drug-allergy interaction checks.3. E-Prescribing (eRx).4. Record demographics.5. Maintain up-to-date problem list.6. Maintain active medication list.7. Maintain active medication allergy list.8. Record and chart changes in vital signs.9. Record smoking status for patients 13 years or older.
15 Core Objectives (we’ll work on)
10. Implement one clinical decision support rule.11. Report ambulatory clinical quality measures to CMS or
states.12. Provide patients with electronic copy of their health
information upon request.13. Provide clinical summaries for patients for each office
visit.14. Capability to exchange key clinical information among
providers of care and patient-authorized entities electronically.
15. Protect electronic health information.
5 of 10 “Menu Set” Objectives
1. Drug-formulary checks.2. Incorporate clinical lab test results as structured data.3. Generate lists of patients by specific condition.4. Send reminders to patients per patient preference for
preventive/follow-up care.5. Provide patients with timely electronic access to their
health information.
5 of 10 “Menu Set” Objectives
6. Use certified EHR technology to identify patient-specific education resources and provide to patient, if appropriate.
7. Medication reconciliation.8. Summary of care record for each transition of care or
referral.9. Capability to submit electronic data to immunization
registries or systems.*10.Capability to provide electronic syndromic surveillance
data to public health agencies.**Must do either #9 or #10.
3 Core Clinical Quality Measures
1. Hypertension: Blood Pressure Management*2. Tobacco Use Assessment and Tobacco Use Intervention
(Pair)*3. Adult Weight Screening and Follow-up
*We’ll focus on patients with diabetes, but these apply to all patients. Key is to apply the system of care to all patients, all populations.
3 More Clinical Quality Measures
1. Diabetes: HbA1C Poor Control (>9.0%)2. Diabetes: Blood Pressure Management3. Diabetes: LDL Management & Control
We will also track:4. Diabetes: HbA1C Control (<8.0%)5. Diabetes: Urine Screening6. Diabetes: Eye Exam7. Diabetes: Foot Exam
COLLECTING DIABETES DATAClinical Measures
Diabetes DenominatorCount of active patients with diabetes 18-75 years old (includes 75 year olds).*• An active patient is one who had two face-to-face
encounters with different dates of service in your office or one face-to-face encounter in an acute inpatient or emergency room setting in the past 2 years with a diagnosis of diabetes.
• Commonly identified using ICD-9-CM codes: 250.xx, 357.2, 362.0, 366.41, 648.0.
*Used for all but tobacco cessation intervention measure.
More Denominator [Total DM Population] Specifics: FAQ• Age range excludes juveniles and frail elderly.• Include Type 1 or Type 2 diabetes.• Include even patients not seen routinely: Population
management!• Include patients co-managed with endocrinology.• Exclude gestational diabetes, polycystic ovarian
syndrome without DM, and steroid-induced diabetes.
Diabetes Numerators/Measures• HbA1C: Poor Control (>9.0%)• HbA1C: Good Control (<8.0%)• Blood Pressure: Control (<140/90 mm Hg)• LDL Cholesterol: Control (<100mg/dL)• Patients Queried on Tobacco Use• Tobacco Users Receiving Tobacco Cessation Intervention• Screening/Attention for Nephropathy• Patients with Yearly Eye Exam• Patients with Yearly Foot Exam• Patients with Self Management Goal
Out
com
e M
easu
res
Proc
ess
Mea
sure
s
HbA1C: Poor Control (>9.0%)
• Count of active diabetes patients ages 18-75 whose most recent A1C level tested within last year is >9.0%• As documented through automated laboratory
data or medical record review.
HbA1C: Good Control (<8.0%)
• Count of active diabetes patients ages 18-75 whose most recent A1C level tested within last year is <8.0%• As documented through automated laboratory
data or medical record review.
• Virtually everyone should be <8.0%
A1C Goal: I thought it was bad to lower A1C too much?• All recent studies (i.e., ACCORD) aimed at A1C
= 6.5 or lower.• No evidence that A1C = 7 is bad.• Data says to reduce CVD—it’s not so much about
glucose.• It’s the Blood Pressure and Cholesterol!
Guidelines for A1C ControlAmerican Diabetes Association• Lowering A1C to below or around 7% has been shown to
reduce microvascular and neuropathic complications by as much as 40%.
• A1C targets below or around 7% in the years soon after a diabetes diagnosis is associated with long-term risk reduction in macrovascular disease.
American Geriatric Society• A less stringent target (e.g., A1C <8%) is appropriate for frail
older adults, persons with <5 year life expectancy, and others with history of severe hypoglycemia.
• A reasonable A1C goal for older adults with good functional status is 7% or lower.
Blood Pressure: Control (<140/90 mm Hg)• Count of active diabetes patients ages 18-75
with most recent systolic blood pressure measurement <140 mm Hg and diastolic blood pressure <90 mm Hg, tested within last year.
• Both systolic and diastolic measurements must be less than the targets noted.
Guidelines for BP Control• Most important measure to control!
• A 10 mm Hg reduction in systolic BP reduces the risk of complications by 12%.
• Good BP control – minimizes CVD and microvascular complications.
• BP goal should be 130/80. We will track 140/90.
Taking and Recording the BP• Sitting vs. standing• White coat syndrome• Right size cuffs• Who takes: clinical assistant or provider?• Be able to record in EMR visit template 2 or
more BP recordings during same visit (so report on most recent).
LDL Cholesterol: Control (<100mg/dL)• Count of active diabetes patients ages 18-75
whose most recent LDL-C level in the past 12 months is <100 mg/dL, • As documented through automated laboratory
data or medical record review.
Guidelines for LDL Control
American Diabetes Association (ADA), American College of Endocrinology (ACE), and American Association of Clinical Endocrinologists (AACE)• Recommend aggressive LDL management to achieve
goal of <100 mg/dL.• STATINS!
Patients Queried on Tobacco Use• Count of active diabetes patients ages 18-75 who
were queried about tobacco use one or more times in the past 24 months.
• Meaningful Use Core Measure #9 and NCQA PCMH 2011: Tobacco query required for ALL patients ages 13 or older.
Tobacco Users Receiving Cessation Intervention
• DIFFERENT DENOMINATOR: Count of active diabetes patients ages 18-75 who use tobacco that received a cessation intervention one or more times in the past 24 months.
• Cessation intervention may include smoking cessation counseling (e.g., advice to quit, referral for counseling) and/or pharmacologic therapy.
• Meaningful Use Preventive/Screening Measure: Tobacco cessation intervention required for ALL patients ages 18 or older who use tobacco.
Screening/Attention for Nephropathy• Count of active diabetes patients ages 18-75 who
have at least one of the following in the past 12 months:• Diagnosis of nephropathy• Nephropathy-related procedure• Laboratory test for urine microalbumin• Laboratory test for nephropathy screening• Medication order for ACE Inhibitor/ARBs• Medication dispensed for ACE Inhibitor/ARBs• Active medication list includes
ACE Inhibitors/ARBs
Why Screen for Nephropathy?• Leading cause of kidney failure.• Preventable with good glucose and blood
pressure control and with ACE/ARB medication.• Once macroprotenuria [dipstick positive], it is
irreversible.
Patients With Documented Eye Exam• The count of diabetes patients ages 18-75 who
had a retinal or dilated eye exam by an eye care professional in the past 12 months.
• Results of exams should be documented in the medical records.
• Requires referral tracking system.• Diabetic retinopathy is a leading cause of
blindness.
Diabetic Foot Exam
• Count of active diabetes patients ages 18-75 who had a foot exam in the past 12 months.
• Foot exam = visual inspection, sensory exam with monofilament, or pulse exam.
• Nearly 60-70% of diabetics suffer from mild or serious nervous system damage.
• Loss monofilament = HIGH RISK• Comprehensive foot care programs can lower
amputation rates by 45-85%.
Patients with Self Mgmt Goal• Count of active diabetes patients ages 18-75 who
have a documented self-management goal in the chart in the past 12 months.
• A self-management goal is a behavioral goal that the patient and provider/care team agree upon during a visit or phone conversation.
• Not a Meaningful Use measure, but needed for NCQA PCMH 2011.
• Examples:• I will walk 10 minutes a day 3 days a week.• I will check my glucose twice a day.• I will not have more than 2 desserts per week.
NCQA PCMH 2011 STANDARDSBecoming Recognized
Widespread ApplicationRecording, using, measuring, and reporting data meets many NCQA 2011 Standards:
• PCMH 2: Identify and Manage Patient Populations• PCMH 3: Plan and Manage Care• PCMH 4: Provide Self-Care Support and Community
Resources• PCMH 5: Track and Coordinate Care• PCMH 6: Measure and Improve Performance
Note: NCQA applies to ALL patientsnot just diabetes patients!
REPORTING YOUR DATAMonthly Status Report
Reporting Is Key!• VERY helpful to have baseline data before you
start testing changes.• Important to measure monthly to see if changes
you are testing are making a difference.• Monthly reporting allows timely feedback to you
from practice facilitators.• Monthly reporting will help set agenda for
monthly conference calls/webinars and future learning sessions.
Monthly Reporting Template• Use template for both data and written status report.• First portion not likely to change much over time.
Monthly Reporting Template• Double-click on data table to enter baseline data.• Note percentages should automatically calculate based on
numerators and denominators you enter.• Goal % is based on HEDIS 90th percentile for NE US or Mid-
Atlantic US. Used in ongoing PA initiative.
Reporting Your Baseline Data• We’ll email the reporting template and measure
specifications to key contacts this week.• Please fill in your (1) team member info, (2) aim
statement, and (3) baseline data on the reporting template and submit it BEFORE your first learning session via email to paspread@hmc.psu.edu.
• We’ll talk about the rest of the report later. The first update isn’t due until July.
Benchmarking Reports• Helps you to see how things are going over time.• PA AHEC data system will provide monthly run charts
and benchmarking reports to facilitate performance assessment/improvement.
Dec
-99
Dec
-01
Dec
-03
Dec
-05
Dec
-07
Dec
-09
Dec
-11
Dec
-13
Dec
-15
Dec
-17
Dec
-19
Dec
-21
Dec
-23
Dec
-25
Dec
-27
Dec
-29
Dec
-31
Dec
-33
Dec
-35
Dec
-37
Dec
-39
Dec
-41
Dec
-43
Dec
-45
Dec
-47
Dec
-49
Dec
-51
Dec
-53
Dec
-55
Dec
-57
Dec
-59
Dec
-61
Dec
-63
Dec
-65
Dec
-67
Dec
-69
Dec
-71
Dec
-73
Dec
-75
Dec
-77
Dec
-79
Dec
-81
Dec
-83
Dec
-85
Dec
-87
Dec
-89
Dec
-91
Dec
-93
Dec
-95
Dec
-97
Dec
-99
Dec
-01
Dec
-03
Dec
-05
Dec
-07
Dec
-09
0
20
40
60
80
100
- 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 0 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1
Pct of DM patients with latest BP <140/90
RESOURCES TO HELP YOUPractice Facilitators
Practice Facilitators
• NorthwestPatricia J. Stubber, MBAExecutive DirectorNorthwest PA AHEC8425 Peach StreetErie, PA 16509-4788814-217-6029 (phone)814-594-4740 (cell)814-864-4077 (fax)pstubber@nwpaahec.org
• South CentralSharon M. Adams RN, BAExecutive DirectorSouthcentral PA AHECPO Box 509Carrolltown, PA 15722814-344-2222 (phone)814-344-2221 (fax)sadams@scpa-ahec.org
Web: www.paspread.comEmail: paspread@hmc.psu.edu
List of Pre-Work To-Do’s Identify a provider champion Form a multi-disciplinary improvement team Write an aim statement Develop a plan to address any issues with provider
panels Complete and submit the PCMH-A assessment Collect and report baseline diabetes data on the
monthly practice status report BEFORE your first learning session
Participate in the 3 pre-work webinars RSVP attendees for Learning Session #1
UPCOMING DATESWebinar #3; Learning Session #1
Dates for Upcoming Sessions• Webinar #2: Baseline Data Measurement
• May 2: 7-8am• May 8: 5-6pm
• Webinar #3: Introduction to the Models• May 16: 7:30-8:30am• May 21: 4-5pm
• NW Learning Session #1: May 23, 5-9pm in Erie• SC Learning Session #1: May 22, 5-9pm in Hershey OR
June 7, 5-9pm in Altoona
Please RSVP the team members who will be attending Learning Session #1 to paspread@hmc.psu.edu by May 11.